AKT1 and acute myeloid leukemia: Of note, this small molecule also showed potent anticancer activity when tested against THP-1 and HL-60 AML cell lines, validating the hypothesis that dual inhibitors targeting PI3K and AKT can efficiently inhibit AML cell proliferation.